You are here

Article metrics

Article menu
Download PDFPDF
PostScript
Letter
Phase 0 trial investigating the intratumoural concentration and activity of sorafenib in neurofibromatosis type 2

 

Online download statistics by month:

Online download statistics by month: February 2019 to September 2024

AbstractFullPdf
Feb 20199305026
Mar 2019808175
Apr 20194861010
May 2019452134
Jun 201932163
Jul 201926781
Aug 201923232
Sep 20195103612
Oct 20192482314
Nov 2019127156
Dec 201999113
Jan 20207483
Feb 20204645
Mar 20206491
Apr 20204310
May 20208742
Jun 20207162
Jul 20206532
Aug 20205933
Sep 20205510
Oct 20205741
Nov 20205522
Dec 20204200
Jan 20216300
Feb 20216522
Mar 20212400
Apr 20215421
May 20213153
Jun 2021743
Jul 2021220
Aug 2021321
Sep 2021112
Oct 202111121
Nov 202110125
Dec 202114613
Jan 202210940
Feb 20226391
Mar 20227652
Apr 20222000
May 202214380
Jun 20227773
Jul 20223010
Aug 2022109188
Sep 20227522
Oct 202210984
Nov 20224751
Dec 20223400
Jan 20233132
Feb 20239620
Mar 20232610
Apr 20231800
May 20231332
Jun 20234111
Jul 202328110
Aug 20235020
Sep 20231610
Oct 20232010
Nov 20233610
Dec 20234232
Jan 20247652
Feb 20243424
Mar 20243300
Apr 20243911
May 202422187
Jun 20248734
Jul 20243933
Aug 20241200
Sep 20242610
Total7682379177